So far this year, markets abroad are leaving U.S. equities in the dust, and some strategists say the outperformance could continue to accelerate.
Health companies have been chasing the problem of non-invasive blood sugar monitoring for decades
CNBC's Meg Tirrell takes a look at how big pharma is responding to President Trump.
Contract manufacturing firm Samsung BioLogics has denied allegations it juggled its accounting practices.
Roche remains committed to the U.S. despite President Donald Trump's pledges to crackdown on pharmaceutical companies "getting away with murder."
Everyone from government to independent foundations are funding microbiome research. Why bacteria's DNA is garnering so much attention.
European markets recovered from session lows to edge into the green at the close on Thursday as the European Central Bank held rates.
Third-quarter sales at the world's biggest maker of cancer drugs rose to $12.61 billion.
Bristol-Myers Squibb's approach to treating lung cancer will have a chance to redeem itself when new data comes out on Sunday.
European stocks traded lower on Monday as the U.S. dollar strengthened after hawkish comments from U.S. Federal Reserve Chair Janet Yellen in a closely watched speech Friday.
Some of the names on the move ahead of the open.
The U.S. Food and Drug Administration issued emergency authorization for a Zika diagnostics test from Swiss drugmaker Roche.
Kevin O'Leary said that companies that are paying out dividends are "hitting it out of the park."
European stocks finished mostly around the flatline after the ECB left its key interest rate unchanged and as investors digested more earnings.
Roche CEO, Severin Schwan explains why the impact of Brexit on the pharmaceutical firm is "rather limited".
Swiss drugmaker Roche on Thursday confirmed its outlook for 2016 and reported sales for the first half of the year ahead of analyst expectations.
Severin Schwan, CEO of Roche, discusses the highlights from the company's earnings results for the first half of 2016.
Shares of BioMarin jumped more than 10 percent in early trading after a report said Roche may be seeking to acquire it.
A broad coalition is urging the U.S. Supreme Court to review the cancellation of a patent on a less risky form of prenatal testing.
European stocks surged by Monday's close, as declining fears of a Brexit vote buoyed global market sentiment, sterling and oil prices.